These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8544921)

  • 1. Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain.
    Howland DS; Savage MJ; Huntress FA; Wallace RE; Schwartz DA; Loh T; Melloni RH; DeGennaro LJ; Greenberg BD; Siman R
    Neurobiol Aging; 1995; 16(4):685-99. PubMed ID: 8544921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
    Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
    Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid.
    Bodendorf U; Danner S; Fischer F; Stefani M; Sturchler-Pierrat C; Wiederhold KH; Staufenbiel M; Paganetti P
    J Neurochem; 2002 Mar; 80(5):799-806. PubMed ID: 11948243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor.
    Pu YZ; Liang L; Fu AL; Liu Y; Sun L; Li Q; Wu D; Sun MJ; Zhang YG; Zhao BQ
    Curr Alzheimer Res; 2017; 14(6):668-679. PubMed ID: 27978793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytical processing of mutated human amyloid precursor protein in transgenic mice.
    Czech C; Delaère P; Macq AF; Reibaud M; Dreisler S; Touchet N; Schombert B; Mazadier M; Mercken L; Theisen M; Pradier L; Octave JN; Beyreuther K; Tremp G
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):108-16. PubMed ID: 9221907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
    Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
    Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice.
    Lamb BT; Call LM; Slunt HH; Bardel KA; Lawler AM; Eckman CB; Younkin SG; Holtz G; Wagner SL; Price DL; Sisodia SS; Gearhart JD
    Hum Mol Genet; 1997 Sep; 6(9):1535-41. PubMed ID: 9285791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.
    Herzig MC; Winkler DT; Burgermeister P; Pfeifer M; Kohler E; Schmidt SD; Danner S; Abramowski D; Stürchler-Pierrat C; Bürki K; van Duinen SG; Maat-Schieman ML; Staufenbiel M; Mathews PM; Jucker M
    Nat Neurosci; 2004 Sep; 7(9):954-60. PubMed ID: 15311281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.
    Kumar-Singh S; Dewachter I; Moechars D; Lübke U; De Jonghe C; Ceuterick C; Checler F; Naidu A; Cordell B; Cras P; Van Broeckhoven C; Van Leuven F
    Neurobiol Dis; 2000 Feb; 7(1):9-22. PubMed ID: 10671319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.
    Johnson-Wood K; Lee M; Motter R; Hu K; Gordon G; Barbour R; Khan K; Gordon M; Tan H; Games D; Lieberburg I; Schenk D; Seubert P; McConlogue L
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1550-5. PubMed ID: 9037091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BACE/APPV717F double-transgenic mice develop cerebral amyloidosis and inflammation.
    Ozmen L; Woolley M; Albientz A; Miss MT; Nelboeck P; Malherbe P; Czech C; Gruninger-Leitch F; Brockhaus M; Ballard T; Jacobsen H
    Neurodegener Dis; 2005; 2(6):284-98. PubMed ID: 16909011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.